VCP ScannerFree US Stock Screener & Financial AnalysisFree US Stock Screener
ScreenerThemes
DCF ValuationCalculate intrinsic value of US stocks
Market ValuationBuffett indicator, CAPE & macro gauges
Total ReturnSee dividends + price return history
DCA CalculatorSimulate recurring buys & compounding
Earnings
FAANG & Tech
AAPL vs MSFTNVDA vs AMDGOOGL vs META
Cloud & Cyber
CRM vs NOWCRWD vs PANWSNOW vs DDOG
Consumer & Auto
TSLA vs FAMZN vs WMTNFLX vs DIS
Finance & Crypto
JPM vs BACV vs MACOIN vs MSTR
Pharma & Energy
LLY vs NVOJNJ vs PFEXOM vs CVX
Compare Any Stocks...
WatchlistInsider
ScreenerThemes
Earnings
WatchlistInsider
AMNAMN Healthcare Services, Inc.
$32.76$1.3B
Overview & Verdict
Overview
Valuation & Forecasts
Valuation ModelsEstimatesDCF Model
Price & Analyst Data
Analyst TargetsPrice HistoryTechnical Analysis
Financial Statements
Income StatementBalance SheetCash FlowRatios & Margins
Performance
P/E HistoryRevenue HistoryEarnings HistoryDividend HistoryTotal Return
Ownership
Holders
← Back to Screener
VCP ScannerFree US Stock Screener & Financial Analysis

Find stocks. Verify deeply. Act with conviction.

Data updated daily

Product

  • Screener
  • Themes
  • Valuation
  • Total Return
  • DCA Calculator
  • News
  • Earnings

Resources

  • Market Valuation
  • Compare
  • Insider Activity
  • Methodology
  • How It Works
  • Glossary
  • Learn

Get Ideas

Get weekly stock ideas — free

© 2026 VCP Scanner
AboutPrivacyTerms
Not financial advice. Do your own research.
ScreenerNewsCompareWatchlist
HomeStocksAMNCash Flow

AMN Healthcare Services, Inc. (AMN) Cash Flow Statement

26Y historyFree accessUpdated daily

Cash flow generation is highly volatile, as demonstrated by the 2026Q1 free cash flow margin of 40.3% which contrasts sharply with the negative 8.9% margin observed in 2023Q4.

AMN Cash Flow Statement

Income StatementBalance SheetCash FlowRatios
AnnualQuarterly
MetricTTMDec'25Dec'24Dec'23Dec'22Dec'21Dec'20Dec'19Dec'18Dec'17Dec'16Dec'15Dec'14Dec'13Dec'12Dec'11Dec'10Dec'09Dec'08Dec'07Dec'06Dec'05Dec'04Dec'03Dec'02Dec'01Dec'00
Cash from Operations739.24M269.46M320.42M372.17M653.73M305.36M256.83M224.86M226.99M115.26M131.85M57.05M27.68M58.64M60.51M19.31M8.09M98.73M63.69M79.64M54.54M44.09M39.04M65.14M56.85M1.68M-1.59M
Operating CF Margin %-9.87%10.74%9.82%12.47%7.66%10.73%10.12%10.63%5.8%6.93%3.9%2.67%5.8%6.34%2.18%1.17%12.99%5.23%6.84%5.04%6.25%6.21%9.12%7.33%0.32%-0.69%
Operating CF Growth %423.63%-15.9%-13.9%-43.07%114.09%18.9%14.21%-0.94%96.94%-12.58%131.1%106.13%-52.8%-3.1%213.34%138.74%-91.81%55.01%-20.02%46.02%23.7%12.94%-40.08%14.59%3286.12%205.86%-
Net Income-32.44M-95.7M-146.98M210.68M444.05M327.39M70.67M113.99M141.74M132.56M105.84M81.89M33.22M32.93M15.95M-26.27M-51.99M-122.18M34.36M36.53M35.09M22.23M17.35M37.79M52.36M-4.39M-5.2M
Depreciation & Amortization116.74M156.6M173.78M160.93M137.11M103.7M94.19M58.52M41.24M32.28M29.62M20.95M15.99M13.54M14.15M16.42M15.08M13.81M14.44M11.67M10.32M6.18M5.84M4.82M3.84M7.71M3.3M
Stock-Based Compensation21.3M30.68M23.32M18.02M30.07M25.22M20.46M16.24M10.81M10.24M11.4M10.28M7.16M6.13M6.22M7.13M8.28M8.71M9.32M8.39M6.8M142K16.1K874K31.88M31.88M0
Deferred Taxes-30.6M-19.55M-51.07M-12.93M-24.61M-16.29M-21.63M913K-667K5.61M-9.42M12.68M11.78M3.03M6.95M-1.79M-10.71M-51.72M-3.37M1.14M18.08M19.02M4.09M6.04M7.29M-8.65M-9.73M
Other Non-Cash Items248.33M96.39M235.46M45.6M67.68M8.84M26.01M16.22M2.25M12.85M11.12M1.58M7.14M1.84M19.51M47.67M57.98M185.6M1.76M2.13M-2.74M4.48M2.44M1.6M-27.58M14.28M27.02M
Working Capital Changes478.08M101.03M85.91M-50.13M-558K-143.49M67.13M18.98M31.61M-78.27M-16.7M-70.33M-47.61M1.16M-2.27M-23.84M-10.56M64.51M7.18M19.77M-13.01M-7.96M9.32M14.02M-10.94M-39.16M-16.98M
Change in Receivables41.69M74.75M219.44M224.85M20.04M-585.27M-8.61M5.71M-10.58M-10.64M-57.16M-98.02M-52.13M-8.45M1.39M-29.02M-15.3M88.73M10.41M5.53M-40.6M-474K0-30.15M-39.48M-39.48M0
Change in Inventory00000-256.12M-5.56M-1.93M14.56M-32.63M-3.34M-7.34M-4M4.33M-12.29M5.6M1.16M0-6.91M8.57M23.83M-106.36M0-36.48M-111.42M-118.81M0
Change in Payables19.06M0000256.12M5.56M1.93M17.15M-7.86M17.7M29.61M6.13M4.34M2.83M3.66M8.94M01.94M1.72M1.18M-1.2M03.66M2.65M2.65M0
Cash from Investing22.84M4.3M-79.94M-412.49M-170.71M-107.4M-538.17M-291.82M-279.34M-33.45M-257.36M-116.83M-28.23M-47.9M2.96M-1.98M-6.85M-29.25M-48.25M-14.63M-45.68M-115.33M-5.06M-14.01M1.45M-33.78M-94.14M
Capital Expenditures-32.9M-35.63M-80.89M-103.69M-75.83M-53.66M-39.1M-36.46M-36.39M-26.53M-21.96M-27.01M-19.13M-9.05M-5.47M-4.65M-4.17M-3.79M-8.79M-9.15M-9.71M-3.82M-5.06M-13.01M-4.33M-4.5M-2.36M
CapEx % of Revenue0.96%1.3%2.71%2.74%1.45%1.35%1.63%1.64%1.7%1.33%1.15%1.85%1.85%0.89%0.57%0.52%0.6%0.5%0.72%0.79%0.9%0.54%0.8%1.82%0.56%0.87%1.02%
Acquisitions-41K65.28M0-292.1M-69.5M-41.26M-476.43M-247.91M-217.36M-1.5M-218.34M-85.07M-14.47M-39.5M00-3.23M0-30.95M-5.48M-35.96M-111.51M0-9.53M-9.53M-12.97M-91.79M
Investments---------------------------
Other Investing68.53M22K-6.76M-26.6M-26.61M-8.99M-7.66M-13.29M-10.67M-8.62M-5.91M-3M10.38M647K8.43M2.67M553K-25.46M-8.5M0000-1M15.31M-19.09M8K
Cash from Financing-261.82M-295.89M-259.45M10.73M-591.87M-34.9M211.49M136.6M37.51M-77.19M126.29M56.2M-2.1M-783K-61.68M-15.3M-26.45M-53.81M-22.33M-50.92M-23.54M86.52M-34.75M-86.47M-33.82M47.21M95.77M
Debt Issued (Net)-250M-285M-250M459.7M0-21.88M240.54M180M120M-44.06M149.68M57M2.23M-681K-53.73M-12.5M-21.86M-53.65M2.04M-37.92M-21.81M89.11M-36.42M137.37M-662K-128.87M45.18M
Equity Issued (Net)-492K00-424.74M-576.77M-2.69M-6.93M-18.7M-67.01M-20.16M-13.26M000530K000-28.45M-16.29M-10.58M2.32M1.93M-219.21M-33.06M177.34M52M
Dividends Paid000000000000000000000000000
Share Repurchases-492K00-424.74M-576.77M-2.69M-6.93M-18.7M-67.01M-20.16M-13.26M-11.91M-4.45M-2.67M-1.07M000-28.45M-18.51M-37.53M0-110K-219.26M-35.16M00
Other Financing-11.32M-10.89M-9.45M-24.23M-15.1M-10.33M-22.13M-24.7M-15.48M-12.97M-10.13M-796K-4.33M262K-8.48M-2.8M-4.59M-156K4.07M3.29M8.86M-4.9M-258K-4.63M-101K-1.26M-1.41M
Net Change in Cash513.81M-22.13M-18.97M-29.6M-108.84M162.72M-69.97M69.64M-14.57M4.53M1.05M-3.5M-2.51M9.9M1.72M2.08M-25.17M15.74M-7.18M14.07M-14.69M15.2M-779K-35.45M24.48M15.11M43K
Free Cash Flow706.34M233.83M239.53M266.78M572.81M251.69M217.72M188.4M190.61M88.73M109.89M30.04M8.54M49.59M55.04M14.66M3.92M94.94M54.9M70.48M44.82M40.27M33.98M52.13M52.52M-2.82M-3.94M
FCF Margin %20.66%8.56%8.03%7.04%10.92%6.32%9.1%8.48%8.92%4.46%5.78%2.05%0.82%4.9%5.77%1.65%0.57%12.5%4.51%6.06%4.14%5.71%5.4%7.3%6.77%-0.54%-1.71%
FCF Growth %172.74%-2.38%-10.21%-53.43%127.58%15.6%15.56%-1.16%114.81%-19.26%265.79%251.63%-82.77%-9.9%275.34%273.99%-95.87%72.94%-22.11%57.25%11.3%18.53%-34.83%-0.75%1963.91%28.55%-
FCF per Share18.066.076.276.7812.775.244.573.963.921.802.230.620.181.041.180.320.112.911.622.021.301.251.081.311.12-0.09-0.18
FCF Conversion (FCF/Net Income)-21.77x-2.82x-2.18x1.77x1.47x0.93x3.63x1.97x1.60x0.87x1.25x0.70x0.83x1.78x3.53x-0.74x-0.16x-0.81x1.85x2.18x1.55x1.98x2.25x1.72x1.09x-0.38x0.31x
Interest Paid42.17M45.11M61.03M48.1M37.52M38.09M22.65M23.73M21.28M17.94M8.06M-5.81M4.6M7.41M13.7M19.67M16.43M7.39M9.6M00000000
Taxes Paid8.61M7.85M28.15M78.26M213.81M106.38M46.26M37.75M30.59M73.75M73.37M-33.13M17.88M18.86M1.86M388K84K5.61M32.95M00000000

Key Metrics

Growth RegimeContracting
ProfitabilityNegative
Balance SheetAdequate
Cash FlowMixed
Top Statement Risk

Cyclical demand normalization

Verified Source

Metrics are mathematically derived from official filings.

SEC 10-K (2026Q1)

Earnings Quality Masked by Accruals

As reported in recent financial filings, AMN's operating cash flow frequently diverges from net income, with the 2025Q1 OCF/NI ratio reaching an extreme -84.86, suggesting that GAAP earnings are heavily distorted by non-cash charges and do not serve as a reliable proxy for underlying cash generation.

The persistent gap between net income and operating cash flow indicates that the company's bottom line is heavily impacted by non-cash items, likely related to impairment charges and amortization from past acquisitions. Investors should monitor this divergence closely, as it suggests that the company's reported profitability is significantly more volatile than its actual cash-generating capacity.

FCF Volatility Amid Revenue Decline

Based on quarterly cash flow data, AMN's free cash flow trajectory remains inconsistent, with margins fluctuating from a negative 8.9% in 2023Q4 to a peak of 40.3% in 2026Q1, reflecting the inherent instability of a business model currently struggling to align costs with contracting demand.

While the 2026Q1 spike in FCF appears impressive, it is largely driven by working capital releases rather than sustainable operational improvements. The underlying trend suggests that without significant revenue stabilization, the company's ability to generate consistent free cash flow remains highly sensitive to the cyclical nature of healthcare staffing.

Capital Intensity Remains Relatively Low

According to historical cash flow statements, AMN maintains a disciplined approach to capital expenditure, with CapEx/Revenue ratios consistently below 4%, suggesting that the business model does not require heavy reinvestment in physical assets to maintain its current service-oriented operations.

The low capital intensity is a positive feature, as it allows the company to preserve liquidity during periods of revenue contraction. However, investors should investigate whether this level of spending is sufficient to support the long-term technological integration required for the company's VMS and workforce solutions strategy.

Working Capital Swings Drive Liquidity

As evidenced by the 2026Q1 data, where working capital changes contributed $409.4M to cash flow, AMN's liquidity is heavily dependent on the timing of receivables and payables, which may indicate significant volatility in the company's ability to collect from hospital clients facing their own financial pressures.

The reliance on working capital fluctuations to bolster cash flow suggests that the company's operational cash cycle is susceptible to external shocks in the healthcare sector. A reversal in these trends could rapidly tighten liquidity, warranting further investigation into the credit quality of the company's primary hospital client base.

AMN — Frequently Asked Questions

Quick answers to the most common questions about buying AMN stock.

How much cash does AMN Healthcare Services, Inc. (AMN) generate from operations?

AMN Healthcare Services, Inc. (AMN) generated $269.5M in net cash from operating activities in 2025. This reflects the cash generated directly from core business operations.

What is AMN Healthcare Services, Inc.'s free cash flow?

AMN Healthcare Services, Inc. (AMN) generated $233.8M in free cash flow in 2025. Free cash flow is the cash left over after capital expenditures, which can be used to pay dividends, repurchase shares, or pay down debt.

What is AMN Healthcare Services, Inc.'s capital expenditure (CapEx)?

AMN Healthcare Services, Inc. (AMN) spent $35.6M on capital expenditures in 2025. CapEx represents the cash invested in physical assets like property, plant, and equipment to maintain or grow the business.